|
1.
|
Number 540
ABSTRACT: Although the risk of venous thromboembolism is increased among oral contraceptive users compared with nonusers who are not pregnant and not taking hormones, and some data have suggested tha...
|
November 2012
PDF Format
|
|
2.
|
Number 539
(Replaces No. 392, December 2007)
ABSTRACT: Long-acting reversible contraception (LARC)—intrauterine devices and the contraceptive implant—are safe and appropriate contraceptive methods for most women and adolescents. The LARC method...
|
October 2012
PDF Format
|
|
3.
|
Number 535
ABSTRACT: Increasing numbers of women and adolescent females are incarcerated each year in the United States and they represent an increasing proportion of inmates in the U.S. correctional system. In...
|
August 2012
PDF Format
|
|
4.
|
Number 512
ABSTRACT: Transgender individuals face harassment, discrimination, and rejection within our society. Lack of awareness, knowledge, and sensitivity in health care communities eventually leads to inade...
|
December 2011
PDF Format
|
|
5.
|
Number 467
(Replaces No. 344, September 2006)
ABSTRACT: The U.S. Food and Drug Administration has approved both a bivalent and quadrivalent human papillomavirus (HPV) vaccine. The Advisory Committee on Immunization Practices has recommended that...
|
September 2010
PDF Format
|
|
6.
|
Number 463
ABSTRACT: Based on several recent studies, new guidelines for initiation of cervical cancer screening have been developed. Evidence shows that screening before the age of 21 years does not change the...
|
August 2010
PDF Format
|
|
7.
|
Number 460
ABSTRACT: The American College of Obstetricians and Gynecologists recommends that the first dedicated reproductive health visit take place between the ages of 13 years and 15 years. This visit will p...
|
July 2010
PDF Format
|
|
8.
|
Number 451
ABSTRACT: Approximately 3 million women in the United States have inherited bleeding disorders. The prevalence of bleeding disorders is particularly high among women with menorrhagia. Von Willebrand ...
|
December 2009
PDF Format
|
|
9.
|
Number 448
(Reaffirmed 2012)
ABSTRACT: Defining the reasons for intervention and the precise goal of treatment are the most critical issues regarding use of interventions to alter menstrual flow in adolescents with disabilities....
|
December 2009
PDF Format
|
|
10.
|
Number 415
ABSTRACT: Although depot medroxyprogesterone acetate (DMPA) is associated with bone mineral density (BMD) loss during use, current evidence suggests that partial or full recovery of BMD occurs at the...
|
September 2008
PDF Format
|
|
11.
|
Number 355
(Reaffirmed 2009, Replaces No. 274, July 2002)
ABSTRACT: Vaginal agenesis occurs in 1 of every 4,000.10,000 females. The most common cause of vaginal agenesis is congenital absence of the uterus and vagina, which also is referred to as mullerian ...
|
December 2006
PDF Format
|
|
12.
|
Number 349
(Reaffirmed 2009)
ABSTRACT: Young patients and their parents often are unsure about what represents normal menstrual patterns, and clinicians also may be unsure about normal ranges for menstrual cycle length and amoun...
|
November 2006
PDF Format
|